Last Updated: 24/11/2022
Mozambique Seasonal Malaria Chemoprevention (SMC): Phase 2
Objectives
To test the feasibility, effectiveness and chemoprevention efficacy of Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) in an area of Mozambique where malaria transmission is highly seasonal.
Principal Institution
Principal Investigators / Focal Persons
External reference
Themes
Date
Sep 2021 — Aug 2022
Total Project Funding
$1.86M
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-033337
Project Site
Related Resources
